Terms: = Colorectal cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6
17 results:
1. Incidence and clinical significance of 491 known fusion genes in a large cohort of Japanese patients with colorectal cancer.
Nanishi K; Hino H; Hatakeyama K; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
Int J Clin Oncol; 2023 Jun; 28(6):785-793. PubMed ID: 37022622
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location.
Hino H; Shiomi A; Hatakeyama K; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
J Gastroenterol; 2022 Jul; 57(7):476-485. PubMed ID: 35449312
[TBL] [Abstract] [Full Text] [Related]
4. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
[TBL] [Abstract] [Full Text] [Related]
5. eif3e-RSPO2 and PIEZO1-RSPO2 fusions in colorectal traditional serrated adenoma.
Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Saito Y; Sekine S
Histopathology; 2019 Aug; 75(2):266-273. PubMed ID: 30916365
[TBL] [Abstract] [Full Text] [Related]
6. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
[TBL] [Abstract] [Full Text] [Related]
7. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness.
Gong X; Yi J; Carmon KS; Crumbley CA; Xiong W; Thomas A; Fan X; Guo S; An Z; Chang JT; Liu QJ
Oncogene; 2015 Sep; 34(36):4692-701. PubMed ID: 25531322
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of eif3e is correlated with colon tumor development and poor prognosis.
Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
[TBL] [Abstract] [Full Text] [Related]
9. RSPO fusion transcripts in colorectal cancer in Japanese population.
Shinmura K; Kahyo T; Kato H; Igarashi H; Matsuura S; Nakamura S; Kurachi K; Nakamura T; Ogawa H; Funai K; Tanahashi M; Niwa H; Sugimura H
Mol Biol Rep; 2014 Aug; 41(8):5375-84. PubMed ID: 24847761
[TBL] [Abstract] [Full Text] [Related]
10. cancer incidence in Khartoum, Sudan: first results from the cancer Registry, 2009-2010.
Saeed IE; Weng HY; Mohamed KH; Mohammed SI
Cancer Med; 2014 Aug; 3(4):1075-84. PubMed ID: 24821265
[TBL] [Abstract] [Full Text] [Related]
11. Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol.
Kuijpers AM; Mirck B; Aalbers AG; Nienhuijs SW; de Hingh IH; Wiezer MJ; van Ramshorst B; van Ginkel RJ; Havenga K; Bremers AJ; de Wilt JH; Te Velde EA; Verwaal VJ
Ann Surg Oncol; 2013 Dec; 20(13):4224-30. PubMed ID: 23897008
[TBL] [Abstract] [Full Text] [Related]
12. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.
Stang A; Fischbach R; Teichmann W; Bokemeyer C; Braumann D
Eur J Cancer; 2009 Jul; 45(10):1748-56. PubMed ID: 19356924
[TBL] [Abstract] [Full Text] [Related]
13. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Schmidt GP; Baur-Melnyk A; Haug A; Utzschneider S; Becker CR; Tiling R; Reiser MF; Hermann KA
Eur Radiol; 2009 Jun; 19(6):1366-78. PubMed ID: 19190917
[TBL] [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
15. Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.
Hu JB; Sun XN; Yang QC; Xu J; Wang Q; He C
World J Gastroenterol; 2006 Apr; 12(16):2610-4. PubMed ID: 16688811
[TBL] [Abstract] [Full Text] [Related]
16. DNA copy number changes at 8q11-24 in metastasized colorectal cancer.
Buffart TE; Coffa J; Hermsen MA; Carvalho B; van der Sijp JR; Ylstra B; Pals G; Schouten JP; Meijer GA
Cell Oncol; 2005; 27(1):57-65. PubMed ID: 15750208
[TBL] [Abstract] [Full Text] [Related]
17. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
[TBL] [Abstract] [Full Text] [Related]
